Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Market News
Reasons to be confident and cautious as ASX shares are bouncing back
Share Market News
2 ASX healthcare shares to buy today
⏸️ ASX Shares
4 outstanding ASX 200 shares to buy with $4,000
Share Market News
Top brokers name 3 ASX shares to buy today
Growth Shares
3 sublime ASX growth shares to buy this month
Share Market News
The 10 ASX stocks worst hit by a Biden US presidential election win
⏸️ Shares to Watch
Broker updates are mixed on these 6 high profile ASX 200 shares
⏸️ Investing
Here's where I would spend $10,000 on ASX shares today
Share Market News
The ASX 200 slid 0.72% lower today
Share Gainers
Why Afterpay, Cochlear, Dicker Data, & Zip shares are charging higher today
Share Gainers
Cochlear (ASX:COH) share price pushes higher on Q1 update
Growth Shares
Got a spare $10,000 to invest? Smart investors should buy these ASX shares
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
